
News|Articles|October 2, 2002
- Pharmaceutical Technology-10-02-2002
- Volume 26
- Issue 10
FDA Launches Major Review of CGMPs
Author(s)Jill Wechsler
FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.
Advertisement
Articles in this issue
over 23 years ago
Understanding Pharmaceutical Flowsover 23 years ago
Cyclodextrins as Sustained-Release CarriersNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
2
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
3
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
4
Women Leading Biotech: Advancing Treatments for Ovarian Cancer
5




